Literature DB >> 26170982

Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma.

Yasunori Tokuhara1, Tatsuya Morinishi2, Toru Matsunaga3, Hiroyuki Ohsaki4, Yoshio Kushida3, Reiji Haba3, Eiichiro Hirakawa2.   

Abstract

Claudins are members of a large family of transmembrane proteins, which are essential in the formation of tight junctions and have previously been associated with the process of tumor progression. Studies have reported the aberrant expression of claudin-1 and claudin-4 in numerous types of cancer. The present study aimed to investigate the expression of claudin-1 and claudin-4 in gastric adenocarcinoma tissue. Surgically resected gastric adenocarcinoma tissue specimens were obtained from 94 patients. Protein expression levels of claudin-1 and claudin-4 were determined using immunohistochemical staining; the association between claudin-1 or claudin-4 expression and various clinicopathological parameters were then analyzed. In gastric adenocarcinoma specimens, the expression rates of claudin-1 and claudin-4 were 43.6 and 87.2%, respectively. Claudin-1 expression demonstrated a significant correlation with histological type (P<0.01) and was significantly higher in well- to moderately-differentiated gastric adenocarcinomas compared with poorly-differentiated tumors. However, no correlation was observed between claudin-4 expression in adenocarcinoma and clinicopathological parameters. In conclusion, downregulation of claudin-1 expression in poorly-differentiated gastric adenocarcinoma may be involved in the biological transformation of tumors. The present findings suggested that claudin-1 may be an important protein associated with histological type and therefore may have potential for use as a prognostic marker for gastric adenocarcinoma. Further studies are required to elucidate the precise mechanism of claudin expression and its involvement in tumor progression.

Entities:  

Keywords:  claudin-1; claudin-4; gastric adenocarcinoma; poorly differentiated; well to moderately differentiated

Year:  2015        PMID: 26170982      PMCID: PMC4487060          DOI: 10.3892/ol.2015.3208

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  47 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

2.  Expression profiling of epithelial plasticity in tumor progression.

Authors:  Martin Jechlinger; Stefan Grunert; Ido H Tamir; Elzbieta Janda; Susanna Lüdemann; Thomas Waerner; Peter Seither; Andreas Weith; Hartmut Beug; Norbert Kraut
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

Review 3.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

4.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

Review 5.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

6.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer.

Authors:  F Krämer; K White; M Kubbies; K Swisshelm; B H Weber
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

7.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme.

Authors:  S Liebner; A Fischmann; G Rascher; F Duffner; E H Grote; H Kalbacher; H Wolburg
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

8.  Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype.

Authors:  Y Soini; S Tommola; H Helin; P Martikainen
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

9.  Gastric and intestinal claudin expression at the invasive front of gastric carcinoma.

Authors:  Yoshiko Matsuda; Shuho Semba; Junya Ueda; Takeichi Fuku; Tadateru Hasuo; Hideki Chiba; Norimasa Sawada; Yoshikazu Kuroda; Hiroshi Yokozaki
Journal:  Cancer Sci       Date:  2007-04-24       Impact factor: 6.716

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  7 in total

1.  Protective effect of bone marrow derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury mediated by claudin-4 in a rat model.

Authors:  Yueliang Zheng; Wenwei Cai; Shengang Zhou; Liming Xu; Chengxing Jiang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 2.  Claudins as biomarkers of differential diagnosis and prognosis of tumors.

Authors:  Olga P Popova; Alla V Kuznetsova; Svetlana Yu Bogomazova; Alexey A Ivanov
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-09       Impact factor: 4.553

3.  Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis.

Authors:  Xiaowan Chen; Junhua Zhao; Ailin Li; Peng Gao; Jingxu Sun; Yongxi Song; Jingjing Liu; Ping Chen; Zhenning Wang
Journal:  Onco Targets Ther       Date:  2016-05-27       Impact factor: 4.147

4.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

5.  Peroxisome proliferator-activated receptor-α expression is associated with histological type in human gastric carcinoma.

Authors:  Tatsuya Morinishi; Yasunori Tokuhara; Kazuki Kajihara; Shunsei Kawakami; Shinichi Tanaka; Hiroyuki Ohsaki; Toru Matsunaga; Emi Ibuki; Eiichiro Hirakawa
Journal:  Mol Clin Oncol       Date:  2021-12-24

Review 6.  Claudin-1, A Double-Edged Sword in Cancer.

Authors:  Ajaz A Bhat; Najeeb Syed; Lubna Therachiyil; Sabah Nisar; Sheema Hashem; Muzafar A Macha; Santosh K Yadav; Roopesh Krishnankutty; Shanmugakonar Muralitharan; Hamda Al-Naemi; Puneet Bagga; Ravinder Reddy; Punita Dhawan; Anthony Akobeng; Shahab Uddin; Michael P Frenneaux; Wael El-Rifai; Mohammad Haris
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

Review 7.  Claudins and Gastric Cancer: An Overview.

Authors:  Itaru Hashimoto; Takashi Oshima
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.